BioEcho, an Admera Health company, has achieved ISO 9001:2015 recertification, reaffirming its dedication to delivering high-quality and sustainable nucleic acid purification solutions. This milestone highlights BioEcho’s focus on operational excellence, continuous improvement, and reliable products that help researchers achieve accurate, reproducible results.

BioEcho Life Sciences has been granted a European patent for its innovative EchoLUTION™ technology, which streamlines DNA and RNA extraction into a single step, delivering fast, high-purity results while cutting plastic use by up to 70%.

BioEcho Life Sciences introduces the EchoLUTION™ Tissue RNA Kit, delivering rapid and sustainable RNA extraction from diverse mammalian tissues. The single-step workflow provides high-quality RNA without phenol/chloroform, enabling efficient, eco-friendly workflows for RT-qPCR and RNA-seq applications.

BioEcho introduces the EchoLUTION™ FFPE RNA Kit, offering researchers a faster, solvent-free solution for RNA extraction from FFPE tissues. The kit delivers high-quality RNA for reliable RT-qPCR and RNA-seq, enhancing transcriptomic analysis while reducing hazardous waste and plastic use.

BioEcho introduces the EchoLUTION™ Buccal Swab DNA Kit, enabling ultra-fast and sustainable DNA extraction from buccal swab samples. With a simplified workflow up to 85% faster than conventional methods, the kit delivers high-quality genomic DNA ready for PCR, sequencing, and genetic testing across human and animal research applications.

BioEcho Life Sciences encourages awareness around organ donation by distributing donor cards to all employees and their families. The initiative aims to inspire reflection and new organ donors while highlighting BioEcho’s broader commitment to improving lives through innovation, sustainability, and community engagement.

BioEcho introduces the EchoLUTION™ FFPE DNA Kit for simplified, rapid, and sustainable DNA extraction from FFPE tissue samples. The single-step workflow eliminates toxic reagents like xylene, reduces processing time by up to 70%, and delivers high-quality DNA ready for PCR, NGS, and epigenetic applications.

BioEcho Life Sciences has received patents in the U.S. and Japan for its innovative EchoLUTION™ technology, which simplifies nucleic acid extraction to a single centrifugation step. The patented method delivers high-quality DNA and RNA faster and more sustainably than traditional silica-based workflows—reinforcing BioEcho’s role as a leader in molecular biology innovation.

BioEcho Life Sciences introduces the EchoLUTION™ Cell Culture RNA Kit, a next-generation solution for efficient and simplified RNA extraction from all types of cultured cells. The single-step workflow delivers premium-quality RNA in less time while minimizing plastic waste and hazardous reagents—offering researchers a faster, more sustainable alternative to traditional methods.